Bendanillo, Silvestre .
HRN: 26-72-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/26/2025
03/04/2025
IV
4.5 Grams
Q 8 Hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes